Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03879239 · ClinicalTrials.gov registry record · NA

Efficacy and Safety of Vibrant Capsule vs. Placebo for the Treatment of Chronic Idiopathic Constipation

A NA study of Chronic Idiopathic Constipation, sponsored by Vibrant.

Completed
Registry status
NA
Development phase
349
Enrollment target
8
Study locations

NCT03879239 is a NA study of Chronic Idiopathic Constipation that has completed, run by Vibrant. The registered enrollment target is 349 participants, below the 716-participant average among 6 other Chronic Idiopathic Constipation trials with a reported enrollment target (51% lower). The trial reports 8 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03879239, a NA study of Chronic Idiopathic Constipation, has completed, sponsored by Vibrant.

COMPLETED
Registry status
NA
Development phase
349 participants
Enrollment target
8
Study locations

Study Summary

The study is a prospective, randomized, multicenter, adaptive design, double blinded, placebo-controlled study, to evaluate the efficacy and safety of Vibrant Capsule vs. placebo in relieving constipation in subjects with Chronic Idiopathic Constipation.

Conditions Studied

Chronic Idiopathic Constipation

Interventions

  • DEVICE Vibrating capsule

Study Locations (8)

Ohio

  • Great Lakes Medical Research LLC - Beachwood
  • Clinical Inquest Center Ltd - Huber Heights
  • Great Lakes Gastroenterology Research - Mentor

Alabama

  • G & L Research, LLC. - Foley

Arizona

  • Del Sol Research Management - Tucson

Georgia

  • Augusta University - Augusta

North Carolina

  • PharmQuest - Greensboro

Tennessee

  • Clinical Neuroscience Solutions dba CNS Healthcare - Memphis

Trial Details

FieldValue
Enrollment Target 349 participants
Start Date 2019-04-08
Est. Completion 2022-01-05
Phase NA

Sponsor

Vibrant

8 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03879239

The ClinicalTrials.gov registry entry for NCT03879239 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 349 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 716-participant average among 6 other Chronic Idiopathic Constipation trials with a reported enrollment target (51% lower). The listed sponsor is Vibrant, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Idiopathic Constipation appearing as the primary indexed condition, and to 1 intervention - of which Vibrating capsule is the first listed.

NCT03879239 reports 8 study locations spanning 6 distinct geographic areas - top geographies include Ohio, Alabama, Arizona.

Frequently Asked Questions

What is clinical trial NCT03879239 about?

NCT03879239 is a clinical study titled "Efficacy and Safety of Vibrant Capsule vs. Placebo for the Treatment of Chronic Idiopathic Constipation". The study is a prospective, randomized, multicenter, adaptive design, double blinded, placebo-controlled study, to evaluate the efficacy and safety of Vibrant Capsule vs. placebo in relieving constipation in subjects with Chronic Idiopathic Constipation.

What is the current status of trial NCT03879239?

This trial is currently completed. It is a NA study. The enrollment target is 349 participants. The study started on 2019-04-08. Estimated completion is 2022-01-05.

What conditions does trial NCT03879239 study?

This clinical trial studies the following conditions: Chronic Idiopathic Constipation.

What interventions are being tested in trial NCT03879239?

The interventions under investigation include: Vibrating capsule (DEVICE).

Who is sponsoring clinical trial NCT03879239?

This trial is sponsored by Vibrant, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03879239 being conducted?

This trial has 8 study locations across Alabama, Arizona, Georgia, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Idiopathic Constipation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chronic Idiopathic Constipation

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.